Edwards Training Village at EACTS 2025
Edwards Training Village: THV Applications with the SAPIEN Platform
Explore the newest advancements in transcatheter aortic valve technology and techniques, along with lifetime management strategies.THV
Thursday 9 Oct 2025
THV applications with the SAPIEN Platform
THV applications with the SAPIEN Platform
Friday 10 Oct 2025
THV applications with the SAPIEN Platform
THV applications with the SAPIEN Platform
THV applications with the SAPIEN Platform
Saturday 11 Oct 2025
THV applications with the SAPIEN Platform
THV applications with the SAPIEN Platform
Clinical data on valves with RESILIA tissue up to 7-year follow-up have been published, with additional follow-up of up to 10 years in process.
Reference: Beaver T, Bavaria JE, Griffith B, et al. Seven-year outcomes following aortic valve replacement with a novel tissue bioprosthesis. J Thorac Cardiovasc Surg. 2024 Sep;168(3):781-791.
Expert opinions, advice and all other information represent contributor’s views and not necessarily those of Edwards Lifesciences.
Medical device for professional use. For a listing of indications, contraindications, precautions, warnings, and potential adverse events, please refer to the Instructions for Use (consult https://eifu.edwards.com where applicable).